Every year more than 19 million patients are diagnosed with cancer. Radiotherapy is a forefront cancer treatment prescribed by over 60% of all cancer cases. However, due to the lack of proper tools for quality and safety monitoring, radiotherapy-related errors are common, causing long-lasting negative consequences in the patients.
In this episode, Joana Melo, Co-Founder and COO at NU-RISE, talks about the issue of errors in radiotherapy and how her startup is solving it with smart technology. More on NU-RISE here: https://www.nu-rise.com/
The goal is to provide the audience with insights on how NU-RISE is tackling the issue of errors in radiotherapy. With their solution, they are contributing to the UN Sustainable Development Goal 3 (Good Health and Well-Being).
The conversation is lead by Cristina Almeida, Head of Platform at MAZE, and followed by a discussion with questions from the audience.
This episode is part of the series LIVE session with the ten startups that make the 2020 cohort of MAZE X, the pan-European impact startup accelerator.